摘要
目的:探讨凋亡抑制蛋白Survivin和Bcl-2表达与非小细胞肺癌(NSCLC)预后之间的关系。方法:将88例NSCLC及5例正常肺组织标本制作成组织芯片,应用免疫组织化学S-P法检测Survivin和Bcl-2的表达,并与临床病理特征及长期生存进行比较分析。结果:Survivin胞浆和胞核阳性表达率分别为94.3%和79.5%,Bcl-2胞浆和胞核阳性表达率分别为54.5%和42.0%,而正常肺组织均为阴性。Survivin胞浆表达与年龄等临床参数无关,而Survivin胞核在吸烟者中表达升高(P=0.002)。Bcl-2胞浆表达在男性、吸烟者、鳞癌、淋巴结无转移者中升高(P<0.01),Bcl-2胞核表达在女性、不吸烟者、腺癌和肿瘤大小为T3和T4者中升高(P<0.05)。Survivin表达与NSCLC病人生存期无关。Bcl-2胞浆表达的病人生存期更长(P=0.005),而Bcl-2胞核表达的病人生存期更短(P=0.012)。多因素分析显示Survivin和Bcl-2不是影响NSCLC预后的独立危险因素。结论:Survivin检测可能有助于NSCLC的诊断,Bcl-2胞浆和胞核表达可能具有相反的预后意义。
Objective: To evaluate the prognostic value of survivin and Bcl-2 in patients with non-small cell lung cancer (NSCLC). Methods: Expression of survivin and Bel-2 was accessed by immunohistochemical staining on tissue mieroarray sections, and the results were compared with relevant clinical and pathologic data. Results: Positive rate of cytoplasmic and nuclear survivin in NSCLC was 94.3% and 79.5%, respectively. Positive rate of cytoplasmic and nuclear Bcl-2 in NSCLC was 54.5% and 42.0%, respectively. Neither survivin nor Bcl-2 expression was observed in normal lung tissues. There was no correlation between cytoplasmic survivin expression and clinical characteristics, but nuclear survivin expression was higher in smokers (P=0.002). Cytoplasmic Bcl-2 expression was significantly higher in groups with male, smokers, squamous cell carcinoma and no lymph node involvement (P〈0.01), and nuclear Bcl-2 expression was significantly higher in groups with male, non-smokers, adenocarcinoma and tumor size with T3 and T4 (P〈0.05). However, survivin expression was not related with survival. Patients with positive expression of nuclear Bcl-2 had worse overall survival (P=0.012), whereas positive expression of cytoplasmic Bcl-2 predicted better overall survival (P=0.005). Multivariate analysis using Cox regression modal showed that neither survivin nor Bcl-2 was the important independent prognostic factor for survival Conclusions: These results indicate that survivin highly expresses in NSCLC. so the ubiquitous expression makes it a polential noval parameter for diagnosis, and cytoplasmic and nuclear expression of Bcl-2 might possess completely opposite prognostic significance in patients with NSCLC.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
2007年第2期92-95,共4页
Chinese Journal of Clinical Oncology
基金
辽宁省科技攻关计划基金资助(编号:2004225004-11
2005225013-7)